Although additional information is needed on the association of proteinuria with accumulated exposure to bevacizumab in patients with HCC, all patients due to receive VEGF inhibition therapy should undergo a thorough assessment of renal function before initiation, including evaluation of serum creatinine.51 This evidence concerns the gene VEGFA and hepatocellular carcinoma.